<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Anesth</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Anesth</journal-id>
      <journal-title-group>
        <journal-title>Journal of Anesthesia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0913-8668</issn>
      <issn pub-type="epub">1438-8359</issn>
      <publisher>
        <publisher-name>Springer Japan</publisher-name>
        <publisher-loc>Japan</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23224835</article-id>
      <article-id pub-id-type="pmc">3680659</article-id>
      <article-id pub-id-type="publisher-id">1531</article-id>
      <article-id pub-id-type="doi">10.1007/s00540-012-1531-2</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Severe colchicine intoxication after self-administration of colchicine concomitantly with loxoprofen</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Yamazaki</surname>
            <given-names>Akinori</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Iranami</surname>
            <given-names>Hiroshi</given-names>
          </name>
          <address>
            <phone>+81-73-4224171</phone>
            <fax>+81-73-4261168</fax>
            <email>runbeerclub@yahoo.co.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nishikawa</surname>
            <given-names>Koichi</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Anesthesiology, Wakayama Medical University, 811-1 Kimiidera, Wakayama City, Wakayama 641-0012 Japan </aff>
        <aff id="Aff2"><label/>Department of Anesthesiology, Japanese Red Cross Society Wakayama Medical Center, 4-20 Komatsubara-dori, Wakayama, Wakayama 640-8269 Japan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>12</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>8</day>
        <month>12</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2013</year>
      </pub-date>
      <volume>27</volume>
      <issue>3</issue>
      <fpage>483</fpage>
      <lpage>484</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>9</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>11</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2012</copyright-statement>
        <license license-type="OpenAccess">
          <license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</license-p>
        </license>
      </permissions>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Colchicine</kwd>
        <kwd>Intoxication</kwd>
        <kwd>Loxoprofen</kwd>
        <kwd>Multiple organ failure</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Japanese Society of Anesthesiologists 2013</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p>To the Editor:</p>
    <p>We describe a patient with gout who developed serious multiple system organ failure after the self-administration of colchicine together with loxoprofen.</p>
    <p>A 38-year-old male (height 175&#xA0;cm, weight 75&#xA0;kg) with no pre-existing diseases had been prescribed colchicine (1 tablet) together with loxoprofen (1 tablet) for gout attack by his family physician. Following the severest pain attack at his toe that he had ever experienced, he self-administered 30 tablets of colchicine (15&#xA0;mg) together with ten loxoprofen tablets (600&#xA0;mg) within a 6-h period. His pain subsided 3&#xA0;h after the last intake of the tablets, but he presented to our medical center because of gastrointestinal symptoms including nausea, vomiting, diarrhea, and hematemesis.</p>
    <p>The patient developed acute renal failure on the second hospital day, and on the third hospital day, he entered a delirious state, with thrombocytopenia, respiratory failure, and severe hypotension. Granulocyte colony stimulating factor (250&#xA0;&#x3BC;g/day) was administered for his severe pancytopenia on hospital days 4&#x2013;7. On hospital day 9, his urine output began to increase, and on hospital day 18, the patient had been successfully weaned from the mechanical ventilation. He was discharged from the hospital on hospital day 26. All of the blood and laboratory parameters on hospital day 25 were within the normal ranges, but alopecia, muscle weakness (MMT 4/5), disappeared ankle tendon reflex, reduced evoked potentials of peripheral nerves, including the median, ulnar, and tibial nerves, remained (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Blood, serum, and coagulation data during the hospitalization of this patient</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Blood, serum, and coagulation data</th><th align="left">Normal range</th><th align="left">Day 1</th><th align="left">Day 2</th><th align="left">Day 3</th><th align="left">Day 4</th><th align="left">Day 5</th><th align="left">Day 6</th><th align="left">Day 7</th><th align="left">Day 18</th><th align="left">Day 25</th></tr></thead><tbody><tr><td align="left">White blood cells (/ml)</td><td align="left">4000&#x2013;7000</td><td align="left">29700</td><td align="left">19500</td><td align="left">6000</td><td align="left">900</td><td align="left">400</td><td align="left">900</td><td align="left">3500</td><td align="left">11400</td><td align="left">8400</td></tr><tr><td align="left">Hemoglobin (g/dl)</td><td align="left">14.0&#x2013;18.0</td><td align="left">17.6</td><td align="left">16.1</td><td align="left">14.4</td><td align="left">11.0</td><td align="left">9.8</td><td align="left">7.9</td><td align="left">7.3</td><td align="left">8.6</td><td align="left">8.7</td></tr><tr><td align="left">Hematocrit (%)</td><td align="left">40.0&#x2013;52.0</td><td align="left">51.7</td><td align="left">47.8</td><td align="left">42.5</td><td align="left">31.7</td><td align="left">27.3</td><td align="left">22.6</td><td align="left">20.5</td><td align="left">24.8</td><td align="left">25.7</td></tr><tr><td align="left">Platelets (/ml)</td><td align="left">15.0&#x2013;40.0</td><td align="left">26.7</td><td align="left">11.0</td><td align="left">2.7</td><td align="left">2.3</td><td align="left">1.5</td><td align="left">1.3</td><td align="left">2.0</td><td align="left">10.2</td><td align="left">28.1</td></tr><tr><td align="left">Prothrombin time (%)</td><td align="left">85&#x2013;120</td><td align="left">36</td><td align="left">45</td><td align="left">76</td><td align="left">87</td><td align="left">87</td><td align="left">93</td><td align="left">95</td><td align="left">77</td><td align="left"/></tr><tr><td align="left">Prothrombin time (INR)</td><td align="left"/><td align="left">2.3</td><td align="left">1.89</td><td align="left">1.21</td><td align="left">1.10</td><td align="left">1.10</td><td align="left">1.05</td><td align="left">1.03</td><td align="left">1.20</td><td align="left"/></tr><tr><td align="left">Activated partial thrombin time (s)</td><td align="left">28&#x2013;40</td><td align="left">56.4</td><td align="left">70.3</td><td align="left">52.0</td><td align="left">47.9</td><td align="left">38.7</td><td align="left">41.7</td><td align="left">40.6</td><td align="left">37.6</td><td align="left"/></tr><tr><td align="left">Fibrinogen (mg/dl)</td><td align="left">200&#x2013;400</td><td align="left">374</td><td align="left">598</td><td align="left">799</td><td align="left">766</td><td align="left">822</td><td align="left">692</td><td align="left">586</td><td align="left">396</td><td align="left"/></tr><tr><td align="left">Alkaline phosphokinase (U/l)</td><td align="left">104&#x2013;338</td><td align="left">2579</td><td align="left">2714</td><td align="left">1323</td><td align="left">565</td><td align="left">481</td><td align="left">359</td><td align="left">327</td><td align="left">179</td><td align="left">229</td></tr><tr><td align="left">Aspartate amino transferase (U/l)</td><td align="left">5&#x2013;40</td><td align="left">375</td><td align="left">405</td><td align="left">344</td><td align="left">210</td><td align="left">188</td><td align="left">177</td><td align="left">115</td><td align="left">80</td><td align="left">29</td></tr><tr><td align="left">Alanine amino transferase (U/l)</td><td align="left">5&#x2013;35</td><td align="left">52</td><td align="left">49</td><td align="left">42</td><td align="left">44</td><td align="left">77</td><td align="left">100</td><td align="left">79</td><td align="left">44</td><td align="left">31</td></tr><tr><td align="left">Lactate dehydrogenase (U/l)</td><td align="left">50&#x2013;400</td><td align="left">12250</td><td align="left">13630</td><td align="left">10740</td><td align="left">4850</td><td align="left">2083</td><td align="left">1115</td><td align="left">835</td><td align="left">1290</td><td align="left">506</td></tr><tr><td align="left">Creatinine phosphokinase (U/l)</td><td align="left">20&#x2013;190</td><td align="left">1058</td><td align="left">1518</td><td align="left">2871</td><td align="left">1937</td><td align="left">929</td><td align="left">283</td><td align="left">383</td><td align="left">799</td><td align="left">36</td></tr><tr><td align="left">Blood urea nitrogen (mg/dl)</td><td align="left">8&#x2013;20</td><td align="left">42</td><td align="left">41</td><td align="left">33</td><td align="left">28</td><td align="left">25</td><td align="left">30</td><td align="left">32</td><td align="left">80</td><td align="left">29</td></tr><tr><td align="left">Creatinine (mg/dl)</td><td align="left">0.6&#x2013;1.5</td><td align="left">4.4</td><td align="left">3.8</td><td align="left">3.5</td><td align="left">2.7</td><td align="left">2.8</td><td align="left">2.6</td><td align="left">2.2</td><td align="left">2.8</td><td align="left">0.9</td></tr><tr><td align="left">C-reactive protein (mg/dl)</td><td align="left">&#x2212;0.3</td><td align="left">35.51</td><td align="left">53.88</td><td align="left">54.25</td><td align="left">26.85</td><td align="left">25.51</td><td align="left">19.05</td><td align="left">21.05</td><td align="left">2.72</td><td align="left">0.95</td></tr></tbody></table></table-wrap></p>
    <p>The first symptom of this patient was that of gastrointestinal tract, followed by the subsequent multiple organ failure, including the cardiovascular, renal, hepatic, respiratory, myeloproliferative, central and peripheral nervous systems, which sequentially developed as precisely described in Stapczynski et al.&#x2019;s review [<xref ref-type="bibr" rid="CR1">1</xref>]. The severity of our patient&#x2019;s colchicine intoxication correlated well to the intake doses; i.e., an oral intake of &lt;0.5&#xA0;mg/kg only exerts gastrointestinal tract symptoms, that from 0.5 to 0.8&#xA0;mg/kg results in multiple organ failure, and an oral intake of &gt;0.8&#xA0;mg/kg can be lethal [<xref ref-type="bibr" rid="CR2">2</xref>]. The total intake of colchicine in this patient was 15&#xA0;mg (0.2&#xA0;mg/kg), and he did not have any pre-existing diseases. The co-administration of macrolides promotes colchicine&#x2019;s toxicities [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>], but, to our knowledge, there has been only one report of colchicine toxicity in association with indomethacin [<xref ref-type="bibr" rid="CR5">5</xref>]. Colchicine, anti-inflammatory drugs (NSAIDs), and corticosteroids are commonly used to treat gout. It would appear that a possible interaction between colchicine and NSAIDs could cause a fatal complication.</p>
  </body>
  <back>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stapczynski</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Rothstein</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Gaye</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Niemann</surname>
              <given-names>JT</given-names>
            </name>
          </person-group>
          <article-title>Colchicine overdose: report of two cases and review of the literature</article-title>
          <source>Ann Emerg Med</source>
          <year>1981</year>
          <volume>10</volume>
          <fpage>364</fpage>
          <lpage>369</lpage>
          <pub-id pub-id-type="doi">10.1016/S0196-0644(81)80239-9</pub-id>
          <pub-id pub-id-type="pmid">7018330</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brvar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ploj</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kozelj</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mozina</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Noc</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bunc</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Case report: fatal poisoning with <italic>Colchicum autumnale</italic></article-title>
          <source>Crit Care</source>
          <year>2004</year>
          <volume>8</volume>
          <fpage>R56</fpage>
          <lpage>R59</lpage>
          <pub-id pub-id-type="doi">10.1186/cc2427</pub-id>
          <pub-id pub-id-type="pmid">14975056</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caraco</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Putterman</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rahamimov</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ben-Chetrit</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Acute colchicine intoxication&#x2014;possible role of erythromycin administration</article-title>
          <source>J Rheumatol</source>
          <year>1992</year>
          <volume>19</volume>
          <fpage>494</fpage>
          <lpage>496</lpage>
          <pub-id pub-id-type="pmid">1578471</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rollot</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pajot</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Chauvelot-Moachon</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Nazal</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Kelaidi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Blanche</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Acute colchicine intoxication during clarithromycin administration</article-title>
          <source>Ann Pharmacother</source>
          <year>2004</year>
          <volume>38</volume>
          <fpage>2074</fpage>
          <lpage>2077</lpage>
          <pub-id pub-id-type="doi">10.1345/aph.1E197</pub-id>
          <pub-id pub-id-type="pmid">15494379</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borr&#xE1;s-Blasco</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Enriquez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sirvent</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Amoros</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Navarro-Ruiz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Reyes</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Acute renal failure associated with an accidental overdose of colchicine</article-title>
          <source>Int J Clin Pharmacol Ther</source>
          <year>2005</year>
          <volume>43</volume>
          <fpage>480</fpage>
          <lpage>484</lpage>
          <pub-id pub-id-type="pmid">16240705</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
